South Africa Targets HIV Reduction with Twice — Yearly Prevention Jab. Johannesburg, South Africa — March 20, 2026 South Africa is poised to implement a twice-a-year HIV prevention jab, aiming to significantly reduce the number of new infections.
According to the European AIDS Treatment Group, if the rollout is successful, the country could see a decrease from an estimated 180,000 infections in 2024 to 47,000 by 2045.
The initiative is part of a broader strategy to combat the HIV/AIDS epidemic in South Africa, which has been heavily affected by the virus.
The jab is designed to offer an additional layer of protection for individuals who may not have access to traditional prevention methods or who are at a higher risk of infection.
The government has not yet provided specific details regarding the timing or logistics of the jab’s rollout.
However, officials are optimistic about the potential impact of the vaccine, which is expected to be distributed to high — risk populations first. Health experts are cautiously optimistic about the jab’s potential, emphasizing the importance of a swift and efficient rollout. Officials commented on the matter.
While the jab is seen as a significant step forward in HIV prevention, challenges remain. Ensuring the vaccine’s availability in all regions, addressing potential skepticism, and maintaining public health infrastructure are among the concerns raised by experts. Further details regarding the vaccine’s introduction and the government’s plans are expected to be announced in the coming weeks.
